Skip to main content

Table 2 Drugs grouped by Anatomical Therapeutic Chemical (ATC) classification code and their relative distribution in clusters C1–C4 based on the similarity of their predicted adverse drug reactions induced by synergistic drug-drug interactions (ADRs)

From: Data-driven prediction of adverse drug reactions induced by drug-drug interactions

ATC code

Classification

All drugs

C1

%

C2

%

C3

%

C4

%

ADR

N

%

A

Alimentary tract and metabolism

64

10

12

14

10

8

~

B

Blood and blood forming organs

12

2

2

1

1

4

~

C

Cardiovascular system

88

14

22

24

11

8

+ +

D

Dermatologicals

19

3

2

0

4

5

–

G

Genito/urinary system and sex hormones

28

5

0

4

6

7

–

H

Systemic hormonal preparations

9

1

0

1

<1

4

–

J

Anti-infectives for systemic use

34

6

6

7

5

5

~

L

Antineoplastic and immune-modulating agents

61

10

1

1

11

20

– –

M

Musculo-skeletal system

45

7

16

7

4

5

+ +

N

Nervous system

167

27

29

28

31

21

~

P

Anti-parasitic products, insecticides, and repellents

10

2

0

0

2

3

–

R

Respiratory system

49

8

6

11

8

7

~

S

Sensory organs

11

2

2

1

2

2

~

V

Various

16

3

3

2

3

2

~

  1. Only drugs that have an ATC classification are included. The last column indicates the propensity of ADRs to be preferentially associated with compounds in clusters C1 and C2 (+ +), have no preferential association with drugs in any cluster (~), or be preferentially associated with compounds in clusters C3 and C4 (– or – –), respectively. Each column sums to 100% and the values indicate the distribution of drugs among the ATC classification for each cluster. The number of DDI-induced ADRs for each drug was highly variable, indicating no systematic variation of DDI-induced ADRs on a per drug basis among the ATC drug classes